Metoclopramide and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metoclopramide (metoclopramide hydrochloride) and Basaglar (insulin glargine). Common drug interactions include cholecystitis infective among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Metoclopramide and Basaglar. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Metoclopramide?

Metoclopramide has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 81,263 Metoclopramide users. Check the latest studies of Metoclopramide.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.



On Jul, 06, 2026

51 people who take Metoclopramide and Basaglar together, and have interactions are studied.

Metoclopramide and Basaglar drug interactions.

What are the common drug interactions of Metoclopramide and Basaglar, by gender? *:

female:

  1. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Culture urine positive
  4. Death
  5. Disease progression
  6. Disease recurrence
  7. Ejection fraction decreased (systolic heart failure)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Generalised oedema (swelling all over the body)
  10. Genital abscess (build up of pus in genital)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  4. Decreased activity
  5. Depression
  6. Gait disturbance
  7. Multiple fractures
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Osteoporosis (bones weak and more likely to break)
  10. Quality of life decreased

What are the common drug interactions of Metoclopramide and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Emotional distress
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Pain
  4. Renal tubular necrosis (death of kidney tubules)
  5. Anaemia (lack of blood)
  6. Asthenia (weakness)
  7. Cardiovascular disorder (heart diseases)
  8. Dyspnoea (difficult or laboured respiration)
  9. Dysstasia (difficulty in standing)
  10. Fatigue (feeling of tiredness)

40-49:

  1. Headache (pain in head)
  2. Pruritus (severe itching of the skin)
  3. Rash
  4. Vision blurred
  5. Death

50-59:

  1. Pain
  2. Spinal compression fracture (fracture due to spinal compression on bone)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Arthralgia (joint pain)
  6. Bone density decreased
  7. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  8. Decreased activity
  9. Depression
  10. Emotional distress

60+:

  1. Fatigue (feeling of tiredness)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Dry eye (lack of adequate tears)
  4. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  5. Visual impairment
  6. Abscess limb (limb infection)
  7. Alopecia (absence of hair from areas of the body)
  8. Anal abscess
  9. Anxiety
  10. Blood creatinine increased

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 19.61%
  2. Diabetes: 8 people, 15.69%
  3. Pain: 8 people, 15.69%
  4. High Blood Pressure: 7 people, 13.73%
  5. Depression: 6 people, 11.76%
  6. Type 2 Diabetes: 6 people, 11.76%
  7. Hiv Infection: 5 people, 9.80%
  8. Stress And Anxiety: 5 people, 9.80%
  9. Indigestion: 5 people, 9.80%
  10. Hepatitis C: 5 people, 9.80%

* Approximation only. Some reports may have incomplete information.

Do you take Metoclopramide and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metoclopramide and Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metoclopramide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metoclopramide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Basaglar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride and insulin glargine (the active ingredients of Metoclopramide and Basaglar, respectively), and Metoclopramide and Basaglar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: